Memphis-based Innova was a key investor in a new round of funding for Memphis-based Silicone Arts Laboratories.

Silicone Arts has completed a Series A Round of funding totaling $1.5 million. In addition to Innova, Dallas-based GPG Ventures was involved in the investment. The company manufactures Dermaflage, a cosmetic synthetic skin that includes a topical filler to conceal scars and wrinkles. Silicone Arts will use the funding to grow its direct to consumer site with the use of videos from real customers. Resources will also be used to grow medical sales channels with a new synthetic skin product that will redefine expectations for band aids.

The Tennessee Department of Economic and Community Development selected the company for a trade mission to Asia in 2012, and Silicone Arts Labs was awarded an “Export Achievement Certificate” by the United States Department of Commerce.

“This capital infusion will enable us to grow awareness for unique products that help restore people’s confidence,” said Oscar Atkinson, Silicone Arts Labs CEO. “We are really excited to have Innova invest in the business, and we are pleased to have Innova’s Jan Bouten join our board. His deep experience in medical device and biosciences will be valuable as we expand our reach with dermatologists and plastic surgeons. We also share a common vision for entrepreneurship in Memphis and hope that our success will encourage others to participate in the Memphis startup community.”

Click here for original article.